Stenotrophomonas maltophilia infections

被引:29
|
作者
Dignani, MC
Grazziutti, M
Anaissie, E
机构
[1] Univ Arkansas Med Sci, Arkansas Canc Res Ctr, Myeloma Inst Res & Treatment, Little Rock, AR 72205 USA
[2] FUNDALEU, Buenos Aires, DF, Argentina
[3] FUNCEI, Buenos Aires, DF, Argentina
关键词
Stenotrophomonas maltophilia; nosoconnial infections; immunocompromised host;
D O I
10.1055/s-2003-37920
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Stenotrophomonas maltophilia is a ubiquitous, gram-negative organism that causes hospital-acquired infections. Persons often come in contact with S. maltophilia through environmental water sources, including hospital tap water or faucets, and it has been associated with nosocomial outbreaks of infection. S. maltophilia often infects debilitated persons and those with underlying medical conditions, including immunosuppression. Manifestations of infection include pneumonia, often in mechanically ventilated patients, bacteremia, skin and soft tissue infection, urinary tract infection, and endocarditis. Treatment of S. mallophilia infection is difficult because the organism is resistant to a number of agents typically used for hospital-acquired infections. In vitro and clinical data indicate that trimethoprim-sulfamethoxazole is the agent of choice. Beta-lactamase inhibitors such as clavulanate are also active, and combination therapy may be indicated for certain serious infections due to S. maltophilia.
引用
收藏
页码:89 / 98
页数:10
相关论文
共 50 条
  • [21] STENOTROPHOMONAS MALTOPHILIA SYNERGIZES WITH PSEUDOMONAS AERUGINOSA IN POLYMICROBIAL AIRWAY INFECTIONS
    McDaniel, M. S.
    Schoeb, T.
    Swords, W. E.
    PEDIATRIC PULMONOLOGY, 2019, 54 : S271 - S271
  • [22] Stenotrophomonas maltophilia Bloodstream Infections in Children and Clinical Outcomes of CeftazidimeTreatment
    Ozenen, Gizem Guner
    Kara, Aybuke Akaslan
    Cem, Ela
    Celebi, Miray Yilmaz
    Kacar, Pelin
    Gulderen, Mustafa
    Bayram, Arzu
    Agin, Hasan
    Karacelik, Mustafa
    Akbay, Sinem
    Bayram, Nuri
    Devrim, Ilker
    JOURNAL OF PEDIATRIC INFECTION, 2023, 17 (02): : 96 - 104
  • [23] Epidemiology, clinical features and prognosis of infections due to Stenotrophomonas maltophilia
    del Toro, MD
    Rodríguez-Baño, J
    Martínez-Martínez, L
    Pascual, A
    Pérez-Cano, R
    Perea, EJ
    Muniain, MA
    ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA, 2006, 24 (01): : 4 - 9
  • [24] Stenotrophomonas maltophilia infections of intact skin: a systematic review of the literature
    Bin Abdulhak, Aref A.
    Zimmerman, Valerie
    Al Beirouti, Bassim T.
    Baddour, Larry M.
    Tleyjeh, Imad M.
    DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 2009, 63 (03) : 330 - 333
  • [25] STENOTROPHOMONAS MALTOPHILIA SYNERGIZES WITH PSEUDOMONAS AERUGINOSA IN POLYMICROBIAL AIRWAY INFECTIONS
    McDaniel, M. S.
    Schoeb, T.
    Swords, W. E.
    PEDIATRIC PULMONOLOGY, 2020, 55 : S154 - S154
  • [26] PREVALENCE OF NOSOCOMIAL STENOTROPHOMONAS MALTOPHILIA INFECTIONS IN ASSIUT UNIVERSITY HOSPITALS
    Thabit, Amany Gamal
    Deaf, Enas Abd-El-Meged
    Elsherbiny, Nahla Mohammad
    Wageah, Ehsan Mohammad
    BULLETIN OF PHARMACEUTICAL SCIENCES, 2014, 37 : 27 - 32
  • [27] Risk factors and clinical characteristics of Stenotrophomonas maltophilia infections in neonates
    Mutlu, Mehmet
    Yilmaz, Gurdal
    Aslan, Yakup
    Bayramoglu, Gulcin
    JOURNAL OF MICROBIOLOGY IMMUNOLOGY AND INFECTION, 2011, 44 (06) : 467 - 472
  • [28] Stenotrophomonas maltophilia External Ventricular Drain Infections A Case Series
    Naureckas Li, Caitlin
    Dixit, Avika
    PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2022, 41 (03) : E107 - E108
  • [29] Clinical and Microbiologic Outcomes in Patients with Monomicrobial Stenotrophomonas maltophilia Infections
    Nys, Cara
    Cherabuddi, Kartik
    Venugopalan, Veena
    Klinker, Kenneth P.
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2019, 63 (11)
  • [30] Emerging infections in vulnerable hosts: Stenotrophomonas maltophilia and Elizabethkingia anophelis
    Lee, Yu-Lin
    Hsueh, Po-Ren
    CURRENT OPINION IN INFECTIOUS DISEASES, 2023, 36 (06) : 481 - 494